Search company, investor...

Predict your next investment

Venture Capital
morningside.com

Investments

231

Portfolio Exits

35

Partners & Customers

3

About Morningside Ventures

Morningside Ventures provides investments in companies via private equity and venture capital. It operates in the manufacturing and construction industries through the private equity portfolio and invests in biotech, digital health, med tech, ag-tech, ed-tech, clean tech fin-tech, prop-tech, and consumer sectors through the venture capital portfolio. The company was founded in 1986 and is based in Newton Center, Massachusetts.

Headquarters Location

1188 Centre Street

Newton Center, Massachusetts, 02459,

United States

Want to inform investors similar to Morningside Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Morningside Ventures

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Morningside Ventures in 4 CB Insights research briefs, most recently on Nov 30, 2021.

Latest Morningside Ventures News

Healthcare & Life Sciences Private Equity Deal Tracker: Viewside Capital and Morningside Invest in Resilience Lab

Nov 29, 2022

8h agoVenture CapitalPrivate EquitythehealthcareinvestorViews: 5 Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release . Resilience Lab , based in New York, is a mental health technology company. Founded in 2019, the company’s platform is designed to help clients connect to therapists and participate in in-person, telehealth or hybrid sessions. Viewside , based in Dallas, is a healthcare private equity firm. The firm is focused on making $3 million to $15 million growth equity investments in small and middle market companies within the healthcare technology and service sectors. Morningside , based in Boston and founded in 1986, makes private equity and venture capital investments in the science and technology sectors. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Morningside Ventures Investments

231 Investments

Morningside Ventures has made 231 investments. Their latest investment was in LovePop as part of their Series B on January 1, 2023.

CBI Logo

Morningside Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/24/2023

Series B

LovePop

$5.04M

Yes

2

11/17/2022

Series A

Resilience Lab

$15M

Yes

Morningside Ventures, Undisclosed Angel Investors, and Viewside Capital Partners

12

9/7/2022

Series A

Otolith Labs

$20M

Yes

4

9/1/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

8/24/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/24/2023

11/17/2022

9/7/2022

9/1/2022

8/24/2022

Round

Series B

Series A

Series A

Seed VC

Series B

Company

LovePop

Resilience Lab

Otolith Labs

Subscribe to see more

Subscribe to see more

Amount

$5.04M

$15M

$20M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Morningside Ventures, Undisclosed Angel Investors, and Viewside Capital Partners

Sources

2

12

4

10

10

Morningside Ventures Portfolio Exits

35 Portfolio Exits

Morningside Ventures has 35 portfolio exits. Their latest portfolio exit was New Amsterdam Pharma on November 22, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/22/2022

Reverse Merger

$99M

4

8/5/2022

IPO

$99M

Public

1

7/14/2022

Reverse Merger

$99M

3

3/10/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/3/2022

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/22/2022

8/5/2022

7/14/2022

3/10/2022

2/3/2022

Exit

Reverse Merger

IPO

Reverse Merger

Acquired

Reverse Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

1

3

10

10

Morningside Ventures Acquisitions

1 Acquisition

Morningside Ventures acquired 1 company. Their latest acquisition was Stealth BioTherapeutics on August 01, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/1/2022

Debt

$99M

$125M

Acq - Pending

1

Date

8/1/2022

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$125M

Note

Acq - Pending

Sources

1

Morningside Ventures Partners & Customers

3 Partners and customers

Morningside Ventures has 3 strategic partners and customers. Morningside Ventures recently partnered with Hartford HealthCare on December 12, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

12/9/2022

Partner

United States

The Morningside Group Teams Up With Hartford HealthCare to Advance Digital Health Innovations.

The Morningside Group and Hartford HealthCare today signed a partnership agreement to advance the development of innovative digital health products and technologies.Together , the organizations will select and work with a series of pilot programs for digital health innovations .

1

12/9/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

5/3/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

12/9/2022

12/9/2022

5/3/2022

Type

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

News Snippet

The Morningside Group Teams Up With Hartford HealthCare to Advance Digital Health Innovations.

The Morningside Group and Hartford HealthCare today signed a partnership agreement to advance the development of innovative digital health products and technologies.Together , the organizations will select and work with a series of pilot programs for digital health innovations .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.